IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma

Esophageal adenocarcinoma (EAC) patients commonly present with advanced stage disease and demonstrate resistance to therapy, with response rates below 40%. Understanding the molecular mechanisms of resistance is crucial for improvement of clinical outcomes. IGFBP2 is a member of the IGFBP family of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Myers, Amy L., Lin, Lin, Nancarrow, Derek J., Wang, Zhuwen, Ferrer-Torres, Daysha, Thomas, Dafydd G., Orringer, Mark B., Lin, Jules, Reddy, Rishindra M., Beer, David G., Chang, Andrew C.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694874/
https://ncbi.nlm.nih.gov/pubmed/26317790
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados